Jeil Pharma Holdings Inc (002620-KS) Stock Split, History Data
Working capital analysis
In terms of working capital, Jeil Pharma Holdings Inc maintains a healthy position.
The total current assets of the company are valued at $384527206646.
This represents a growth rate of 8.957% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $37038628042, exhibiting a growth rate of 6.557% year-on-year.
The receivables, another significant portion of the current assets, are valued at $198695148850.
The year-on-year growth rate for receivables is 9.592%.
The inventory, which forms a critical part of the assets, is valued at $125280103149.
This represents a healthy year-on-year growth of 10.607%
On the liabilities side, the company's current liabilities total $412635828783.
This reflects a growth rate of 15.099% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
37038.63
34759.51
28580.78
20183.39
21236.95
41098.11
Receavebles
198695.15
181304.52
167948.96
180962.56
182090.82
195581.84
Inventory
125280.10
113265.72
114242.90
124150.48
96784.32
97562.76
Other
1420.97
4943.53
5728.18
0.00
4633.19
0.00
Total Current Assets
384527.21
352916.44
335143.72
335074.17
313620.34
337927.94
Acc Payable
154050.03
162967.42
159388.34
149264.53
157545.16
151126.76
Short Term Debt
161332.50
119087.35
94964.49
137208.89
108492.88
95171.54
Other Current Liab
95305.22
74661.97
17971.90
15149.11
14367.39
32833.65
Current Liabilities
412635.83
358504.74
298023.55
327317.45
313828.87
280976.70
Capital Structure
When examining the capital structure of Jeil Pharma Holdings Inc, it is clear that the company manages a robust portfolio.
The value of their total assets clocks in at $879996990707.
When juxtaposed with the previous year, this marks a growth rate of 1.654%, showcasing the company's ability to steadily grow its asset base.
Turning to liabilities, the company has total liabilities amounting to $477810922325.
Compared to the prior year, this reflects a growth rate of 7.160%.
The long-term debt forms a sizable part of these liabilities, coming in at $10500000000.
Over the last year, the long-term debt has grown by -39.921%.
On the asset side, the cash and equivalent reserves are worth $37038628042.
The year-on-year growth of these reserves is 6.557%.
The company's common stock, another important asset, holds a value of $7986677500, growing at a rate of 0.000% from the previous year.
Finally, the company's retained earnings stand at $-14357466000, marking a growth rate of -114.614% year-over-year.
These earnings represent the profits that Jeil Pharma Holdings Inc has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$879,996.99
Total liabilities
$477,810,922,325.00
Long term debt
$10,500.00
Cash and eqv
$37,038,628,042.00
Goodwill
$44,862.27
Retained earnings
-$14,357,466,000.00
Common stock
$7,425.00
Enterprise Value
$0.78
Historical dividend key summary
Jeil Pharma Holdings Inc's dividend per share is $50, showing the earnings shared with shareholders per share. It has grown by 0.000% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years
Q1
Q2
Q3
Q4
Total
2024
0.000
50.000
0.000
0.000
50.000
2023
0.000
50.000
0.000
0.000
50.000
2022
0.000
65.000
0.000
0.000
65.000
2021
0.000
70.000
0.000
0.000
70.000
2020
0.000
70.000
0.000
0.000
70.000
2019
0.000
70.000
0.000
0.000
70.000
2018
0.000
60.000
0.000
0.000
60.000
2016
0.000
0.000
0.000
239.212
239.212
2015
0.000
0.000
0.000
205.039
205.039
2014
0.000
0.000
0.000
205.039
205.039
2013
0.000
0.000
0.000
136.693
136.693
2012
0.000
0.000
0.000
205.039
205.039
2011
0.000
0.000
0.000
307.559
307.559
2010
0.000
0.000
0.000
341.732
341.732
2009
0.000
0.000
0.000
341.732
341.732
2008
0.000
0.000
0.000
205.039
205.039
2007
0.000
0.000
0.000
358.819
358.819
2006
0.000
0.000
0.000
341.732
341.732
2005
0.000
0.000
0.000
392.992
392.992
2004
0.000
0.000
0.000
375.905
375.905
2003
0.000
0.000
0.000
341.732
341.732
2002
0.000
0.000
0.000
341.732
341.732
2001
170.866
0.000
0.000
239.212
410.078
2000
66.663
0.000
0.000
0.000
66.663
Net earnings per share (EPS)
Jeil Pharma Holdings Inc has an EPS of $-519.76, which signifies the profit allocated per share of common stock. With a growth rate of 90.409% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years
Q1
Q2
Q3
Q4
Total
2023
1177.89
81.97
-16.95
-1762.67
-519.76
2022
-312.13
-27.17
-184.63
-4895.06
-5418.99
2021
57
131
66
-480.83
-226.83
2020
269
199
103
173.61
744.61
2019
106
168
137
-6322.22
-5911.22
2018
363
519
455
548.04
1885.04
2017
266.55
179778.35
-494
24893.13
204444.03
2016
519.43
823.57
1076.46
4118.65
6538.11
2015
300.72
973.94
973.94
-
2248.60
2014
266.55
895.34
112.77
-714.62
560.04
2013
642.46
181.12
184.54
-877.52
130.60
2012
1172.14
902.17
1161.89
-344.01
2892.19
2011
2617.67
1223.4
3075.59
5.27
6921.93
2010
1500.2
1196.06
2033.31
1781.97
6511.54
2009
1657.4
2002.55
2132.41
1372.03
7164.39
2008
792.82
1725.75
1096.96
870.93
4486.46
2007
610.57
898.76
1165.48
867.67
3542.48
Brief information
Jeil Pharma Holdings Inc (002620.KS) stock split history
Understanding the historical stock splits of Jeil Pharma Holdings Inc (002620.KS) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on July 17, 2017 with a ratio of 0.292627:1. Throughout its history, the company has undergone 3 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
